Loading the records…
Loading the records…
HR7749, the 'Quantum in Practice Act,' is an early-stage bill that adds 'quantum molecular modeling or simulation' to the National Quantum Initiative Act's research program scope. It authorizes zero new funds and has been referred to committee. Near-term revenue impact on pure-play quantum stocks and diversified tech giants is zero.
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
No current market impact from this bill. IONQ ($43.14), RGTI ($16.44), and QBTS ($19.09) have seen significant 30-day appreciation (49.64%, 17.09%, and 32.29% respectively) driven by factors unrelated to HR7749. IBM ($226.33) is down 6.63% over 30 days. Investors should not attribute these moves to a bill with zero funding authorization that is in early committee stage. Any quantum sector tailwind from this legislation would require years to materialize through separate appropriations.
What happened: On March 2, 2026, Rep. Feenstra (R-IA) introduced HR7749, the 'Quantum in Practice Act,' which was referred to the House Committee on Science, Space, and Technology. The bill amends the National Quantum Initiative Act to include 'modeling, simulation,' in the definition of quantum information science, and adds 'quantum molecular modeling or simulation' as a research program element. This is a procedural, policy-signal bill with no funding authorization. It has 12 cosponsors (bipartisan) and is in early committee stage.
The money trail: There is no money in this bill. It authorizes $0 in new funds. The National Quantum Initiative Act already authorizes existing appropriations (roughly $1.2B over 5 years across NIST, DOE, and NSF). HR7749 simply expands the scope of what existing research programs can cover—if agencies choose to reallocate internal resources. Actual spending increases would require a separate appropriations bill and reauthorization.
Structural winners and losers: Pure-play quantum computing companies (IONQ, RGTI, QBTS) and diversified tech giants with quantum programs (IBM, GOOGL) are long-term tailwind beneficiaries of any policy that signals federal commitment to quantum simulation. However, with no new funds authorized, the competitive dynamics do not change today. No company sees a revenue or contract increase.
Real market data: As of April 30, 2026, IONQ trades at $43.14 (30-day +49.64%), RGTI at $16.44 (30-day +17.09%), QBTS at $19.09 (30-day +32.29%). These sharp gains reflect broader quantum market enthusiasm, not HR7749. The bill was introduced two months ago and the market has not reacted to it specifically. IBM at $226.33 (30-day -6.63%) shows no quantum-related catalyst.
Timeline: The bill must pass the House Science Committee, the full House, the Senate, and be signed by the President. With zero funding attached, and in an election year (119th Congress second session), passage probability is low. Even if passed, the impact is purely directional.
Cross-referenced against federal contracts, SEC insider filings & congressional trade disclosures
Multiple independent sources confirm this signal’s market thesis
Matched on shared policy language across AI analyses, with ticker & timing weight
To reauthorize the National Quantum Initiative Act, and for other purposes.
National Quantum Initiative Reauthorization Act of 2026
Quantum Readiness and Innovation Act of 2025
To amend the National Quantum Initiative Act relating to certain health and workforce matters, and for other purposes.
Executive orders & memoranda affecting the same sectors or companies
This proclamation initiates negotiations to adjust imports of wind turbines and their components under Section 232, citing national security concerns including cybersecurity vulnerabilities, radar interference, and grid reliability. It does not immediately impose tariffs but sets the stage for potential trade restrictions, and notes that certain wind turbine components made of aluminum, steel, or copper are already subject to existing tariffs.
This executive order establishes a Women's Health Division within the NIH to coordinate and accelerate research on understudied women's health conditions, and creates a White House Women's Health Task Force to drive policy reforms and translation of research into clinical practice across federal agencies. It directs specific agencies to prioritize research, data collection, and translation into prevention, diagnosis, and treatment, with a focus on all life stages from infancy through aging.
The executive order directs the General Services Administration to create America.gov, a unified digital portal for federal services, integrating Login.gov for authentication and requiring agencies to expose their digital services via APIs. It also mandates the use of AI (referred to as 'super intelligence') with transparency safeguards, while preserving existing service channels and excluding tax and defense/intelligence services.
Free — no credit card
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →